-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OkBsJm8k8PLBu3JgaCcGW4y31KNFBN+BuhS2YW5xPBom8MJfbCYjiaHHp7WVOFQH o4IuDtGamEucv2kxO2RP2g== 0000897069-08-001078.txt : 20080620 0000897069-08-001078.hdr.sgml : 20080620 20080620143510 ACCESSION NUMBER: 0000897069-08-001078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080618 FILED AS OF DATE: 20080620 DATE AS OF CHANGE: 20080620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SABEL IVAN R CENTRAL INDEX KEY: 0001217563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 08909909 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 dkm1537_ex.xml X0202 4 2008-06-18 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217563 SABEL IVAN R TWO BETHESDA METRO CENTER SUITE 1200 BETHESDA MD 20814 1 1 0 0 Chairman of the Board Common Stock 2008-06-18 4 S 0 4 15.08 D 387592 D Common Stock 2008-06-18 4 S 0 22500 15.10 D 365092 D Common Stock 2008-06-18 4 S 0 4196 15.11 D 360896 D Common Stock 2008-06-18 4 S 0 600 15.1125 D 360296 D Common Stock 2008-06-18 4 S 0 100 15.1175 D 360196 D Common Stock 2008-06-18 4 S 0 2100 15.12 D 358096 D Common Stock 2008-06-18 4 S 0 1500 15.13 D 356596 D Common Stock 2008-06-18 4 S 0 2900 15.14 D 353596 D Common Stock 2008-06-18 4 S 0 1100 15.15 D 352596 D Common Stock 1100 I Spouse's IRA Option to Buy 22.3125 1999-12-15 2008-12-14 Common Stock 100000 100000 D Option to Buy 14.75 2000-04-29 2009-04-28 Common Stock 150000 150000 D Option to Buy 1.64 2002-05-31 2009-05-30 Common Stock 75000 75000 D Option to Buy 14.23 2003-05-30 2012-05-29 Common Stock 100000 100000 D Option to Buy 13.80 2004-08-01 2013-07-31 Common Stock 90000 90000 D Includes (i) unvested restricted shares which total 77,500 shares of stock from an initial grant of 77,500 shares of restricted stock made on August 9, 2007; (ii) unvested restricted shares and fully vested shares which total 70,000 shares of stock from an initial grant of 140,000 shares of restricted stock made on June 12, 2006; and (iii) unvested restricted shares and fully vested shares which total 30,450 shares of stock from an initial grant of 75,000 shares of restricted stock made on March 4, 2005. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option becomes exercisable to the extent of 25% of the shares underlying the option on the above date and is cumulatively exercisable to the extent of 25% of the shares underlying the option at the end of each year thereafter. This option was fully vested on June 23, 2005. /s/ Teri L. Champ, Attorney-in-fact 2008-06-20 EX-24 2 dkm1537a.htm

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS that the person whose signature appears below hereby constitutes and appoints Jay W. Freedman, Arthur H. Bill, Thomas L. James, Christian P. Fonss, Timothy C. Maples, Teri L. Champ, Mariel I. Estigarribia and Matthew B. Bronson, or any one of them, such person’s true and lawful attorney-in-fact and agent, with full power of substitution and revocation, for such person and in such person’s name, place and stead, to sign any report on Form 3, Form 4 or Form 5, in any such case with respect to his or her beneficial ownership of shares of Hanger Orthopedic Group, Inc., common stock, $.01 par value per share (“Common Stock”), and to file the same with the Securities and Exchange Commission and any exchange or similar system for trading on which the Common Stock is or hereafter becomes listed or qualified for trading or quoting.

Dated: May 8, 2008


	/s/ Ivan R. Sabel
	(Signature)
	Ivan R. Sabel
	(Printed Name)
	Chairman of the Board and Director
	(Title)

-----END PRIVACY-ENHANCED MESSAGE-----